XEMPERIA is developing a blood test for the early detection of breast cancer leveraging the body’s natural immune response to cancer. This enables detecting the “danger signal” generated by an emerging tumor with high sensitivity. Our solution has the potential to make breast cancer screening more accessible, efficient, and effective to save more lives.